Clicky

Invitae Corporation(NVTA)

Description: Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.


Keywords: Medicine Cancer Biology Telemedicine Telehealth Medical Test Neurological Disorders Genetics Molecular Diagnostics Medical Genetics Software Tools Neurology Urological Disorders Informatics Lab Testing Genetic Disorder Hereditary Cancer Cardiovascular Disorders Genetic Counseling

Home Page: www.invitae.com

NVTA Technical Analysis

1400 16th Street
San Francisco, CA 94103
United States
Phone: 415 374 7782


Officers

Name Title
Mr. Kenneth D. Knight Pres, CEO & Director
Ms. Yafei Wen Chief Financial Officer
Mr. Thomas R. Brida Gen. Counsel, Chief Compliance Officer & Sec.
Dr. Robert L. Nussbaum M.D. Chief Medical Officer
Ms. Shelly D. Guyer Chief Sustainability Officer
Mr. Robert F. Werner Chief Accounting Officer & Principal Accounting Officer
Ms. Hoki Luk Head of Investor Relations and Capital Markets
Mr. Lee Bendekgey J.D. Chief Policy Officer
Glenn Medalle Head of Talent
Ms. Desarie French Chief Talent Officer

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.3178
Price-to-Sales TTM: 0.9413
IPO Date: 2015-02-12
Fiscal Year End: December
Full Time Employees: 3000
Back to stocks